India, June 25 -- Shares of Portage Biotech Inc. (PRTG) gained over 10% on Wednesday morning after the company announced that it regained full compliance requirements for continued listing on Nasdaq Capital Market.
PRTG is currently trading at $6.28, up $0.58 or 10.06%, on the Nasdaq. The stock opened its trading at $6.13 after closing Tuesday at $5.70. The stock has traded between $2.10 and $23.01 in the past 52-week period.
Portage Biotech is a clinical-stage immuno-oncology company advancing a pipeline of novel biologics to transform the immune system's ability to fight cancer.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....